Stock News - Aquestive Therapeutics, Inc. $AQST
Latest Stock News for $AQST
Aquestive Therapeutics Completes FDA Type A Meeting for Anaphylm NDA Resubmission
Expected Stock impact: Noticeably Positive
2026-03-30 11:46:32
Aquestive Therapeutics Announces Leadership Changes and New Chief Legal Officer
Expected Stock impact: Slightly Positive
2026-03-20 15:00:35
